If South Africa is forced to go into a COVID-19 lockdown again, HIV support groups and adherence clubs should remain functional to make sure that everyone is supported, has regular access to information and treatment, and that people are motivated to adhere to treatment, argue Annah Maluleke and Solanga Milambo.
HIV medicines for children often taste bitter, pills are large, and for many children there is a lot of medication to take. This makes it hard to take treatment as prescribed. Tiyese Jeranji looks at the challenges with currently available HIV medicines for children, what innovations are in the pipeline, and how HIV treatment is being tailored to suit the needs of children.
While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.
In 2018, Cabinet adopted a new intellectual property policy for South Africa, but as yet the policy has not led to any change in the country’s patent laws. Amending these laws as soon as possible is critical to both the COVID-19 and HIV response, argues Umunyana Rugege.
Almost nine months since the Commission on Gender Equality (CGE) released a damning report with dozens of women living with HIV’s testimonies about forced sterilisations allegedly performed on them in public health facilities, the Department of Health has now moved to implement the Commission’s recommendations. Nomfundo Xolo reports.
Voluntary Medical Male Circumcision (VMMC) has been shown to reduce the risk of female-to-male HIV transmission by 60%. But with the COVID-19 pandemic and the associated lockdown, health authorities and organisations conducting VMMC in South Africa, say the numbers of men and boys being medically circumcised have dropped dramatically. Siyabonga Kamnqa reports.
New estimates of HIV in South Africa’s provinces were made public last week. This interactive table shows how South Africa’s nine provinces compare on the UNAIDS 90-90-90 targets.
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.
Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.
Dr Thembisile Xulu was recently appointed as the new CEO of the South African National AIDS Council (SANAC). On her second day in office, Bienne Huisman spoke to Xulu about her new role, her love of medicine, and growing up in a family of strong women.
